Abstract

Krüppel-like factor 14 (KLF14) is a member of the Cys2/His2 zinc-finger DNA-binding proteins. Despite strong evidence showing that a polymorphism in the Klf14 gene is closely linked to the development of type 2 diabetes, the physiological and metabolic functions of KLF14 still remain unclear. In the present study, we investigated the role of KLF14 in the regulation of hepatic gluconeogenesis. Adenoviruses expressing KLF14 (Ad-Klf14) or KLF14-specific shRNAs (Ad-shKlf14) were injected into normal C57BL/6J, db/db diabetic, or high-fat diet-induced obese (DIO) mice. Gene expression, hepatic glucose production, glucose tolerance, and insulin resistance were tested in C57BL/6J, db/db, and DIO mice and primary hepatocytes. Our results demonstrate that KLF14 expression is induced in the livers of normal C57BL/6J mice upon fasting and significantly up-regulated in the livers of db/db mice, suggesting a physiological link between KLF14 and gluconeogenesis. Adenovirus-mediated overexpression of KLF14 in primary hepatocytes increased both the mRNA and protein levels of peroxisome proliferator-activated receptor-γ coactivator 1α (Pgc-1α, also known as Ppargc1a), thereby stimulating cellular glucose production. Conversely, knockdown of KLF14 expression led to a reduction in PGC-1α, subsequently inhibiting glucose output in primary hepatocytes. Finally, forced expression of KLF14 in the livers of normal mice increased the plasma glucose levels and impaired glucose tolerance; in contrast, KLF14 knockdown in diabetic mouse livers improved glucose tolerance. Taken together, our data strongly indicate that KLF14 modulates hepatic gluconeogenesis.

Highlights

  • Krüppel-like factor 14 (KLF14) is a member of the Cys2/His2 zinc-finger DNA-binding proteins

  • Genetic evidence from various studies has shown that Klf14 is closely related to metabolic diseases, including neonatal/juvenile diabetes and metabolic syndrome with obesity-associated insulin resistance, leading to adult Type 2 diabetes (T2D) [15, 16, 24]

  • The results demonstrated that overnight fasting led to a significant induction in both Klf14 mRNA and protein levels in the liver and that the induction was restored upon refeeding (Fig. 1A)

Read more

Summary

The abbreviations used are

T2D, type 2 diabetes; Ad-gfp, adenovirus containing green fluorescent protein; Ad-Klf, adenovirus expressing KLF14; Ad-shCtrl, control adenovirus expressing short-hairpin RNA against luciferase; Ad-shKlf, adenovirus expressing short hairpin RNA against KLF14; DEX, dexamethasone; DIO, diet-induced obese; FSK, forskolin; GTT, glucose tolerance test; ITT, insulin tolerance test; PEPCK, phosphoenolpyruvate carboxykinase; PTT, pyruvate tolerance test; TG, triglyceride; FFA, free fatty acid; HFD, high-fat diet; ALT, alanine aminotransferase; AST, aspartate aminotransferase; qPCR, quantitative PCR. PGC-1␣ expression is tightly regulated in response to low systemic glucose levels. PGC-1␣ transactivates gluconeogenic gene expression by coactivating a variety of transcription factors, including hepatic nuclear factor-4␣ (HNF4␣), glucocorticoid receptor, forkhead box O1 (FOXO1), and cAMP-responsive element–binding protein [22]. These transcription factors bind to the promoter regions of genes that encode key gluconeogenic enzymes, such as phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase [23]. Our results indicated that adenovirus-mediated overexpression of KLF14 in mouse primary hepatocytes increased the master regulator of hepatic gluconeogenesis, PGC-1␣, as well as PGC-1␣ target gene expression. The present study demonstrated that the KLF14 is a critical physiological regulator of hepatic gluconeogenesis

Results
Discussion
Experimental procedures
Analytical procedures and chemicals
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call